Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01874665 |
| Title | A Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor |
| Acronym | GIST |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Ariad Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital, Site #047 | Boston | Massachusetts | 02114 | United States | Details | |
| Dana-Farber Cancer Institute, Site #008 | Boston | Massachusetts | 02215 | United States | Details | |
| Oregon Health & Sciences University, Site #048 | Portland | Oregon | 97239 | United States | Details | |
| Fox Chase Cancer Center, Site #012 | Philadelphia | Pennsylvania | 19111 | United States | Details |